3 Biotech Stocks to Be Thankful for This Year

FAN Editor

Anyone who has been holding onto shares of Loxo Oncology Inc. (NASDAQ: LOXO), Nektar Therapeutics (NASDAQ: NKTR), or Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) will have plenty to say when it’s their turn to share at the dinner table this Thanksgiving.  Continue Reading Below Surprisingly positive trial results for experimental cancer therapies helped shares […]

3 Key Things NVIDIA’s CEO Wants Investors to Know

FAN Editor

NVIDIA (NASDAQ: NVDA) reported robust fiscal third-quarter 2018 results on Nov. 9. The graphics-chip specialist’s revenue grew 32%, GAAP earnings per share (EPS) soared 60%, and EPS adjusted for one-time factors jumped 41%. Revenue and earnings both comfortably beat Wall Street’s expectations.   Continue Reading Below A string of strong quarterly results […]

3 Reasons I Just Bought Pandora Stock

FAN Editor

It’s fair to say that Pandora (NYSE: P) is out of favor these days. The digital-music pioneer hit all-time lows earlier this week, after posting uninspiring quarterly results. With its user base gradually shrinking, it’s easy to see why investors are steering clear of the former market darling.  Continue Reading Below Some […]

Can You Count on Social Security When You Retire?

FAN Editor

Social Security is arguably the most important social program for our nation’s retired workers. Each month, more than 42 million of the 61.6 million people receiving a monthly stipend from the Social Security Administration are retired workers. Of these retirees, more than three out of five (62%) rely on their payout […]

Checking In on Fitbit’s Rebuilding Year

FAN Editor

Fitbit (NYSE: FIT) stock is down over 15% year to date as the company executes on its self-proclaimed “transition year”. The most recent quarter wasn’t one to write home about either, but looking under the covers, you’ll see improvements in the business fundamentals. Continue Reading Below Over the past year, the […]